Differential coding potential of ADAM22 mRNAs

Gene

Volumn 403, Issue 1-2, 2007, Pages 80-88

  Godde N J ^a   D'Abaco, G M ^b   Paradiso, L ^a   Novak, U ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

ADAM; Glioma; Splice variants; Transcriptional initiation; Upstream AUGs

Indexed keywords

ADAM PROTEIN; ADAM22 PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CODON; CONTROLLED STUDY; EXON; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; RNA TRANSLATION; TRANSCRIPTION INITIATION;

ADAM PROTEINS; ALTERNATIVE SPLICING; BRAIN; CELL LINE; CELL LINE, TUMOR; CODON; CODON, TERMINATOR; DNA PRIMERS; EXONS; EXPRESSED SEQUENCE TAGS; GENES, REPORTER; GLIOMA; HUMANS; KIDNEY; LUCIFERASES; NEOPLASM STAGING; NERVE TISSUE PROTEINS; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; TRANSCRIPTION INITIATION SITE;

EID: 34748920696     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.07.033     Document Type: Article

References (31)

1. Bendtsen J.D., Nielsen H., von Heijne G., and Brunak S. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340 (2004) 783-795
2. D'Abaco G.M., Ng K., Paradiso L., Godde N.J., Kaye A., and Novak U. ADAM22, expressed in normal brain but not in high-grade gliomas, inhibits cellular proliferation via the disintegrin domain. Neurosurgery 58 (2006) 179-186 (discussion 179-186)
3. Fukata Y., Adesnik H., Iwanaga T., Bredt D.S., Nicoll R.A., and Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313 (2006) 1792-1795
4. Godde N.J., D'Abaco G.M., Paradiso L., and Novak U. Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members. J. Cell. Sci. 119 (2006) 3296-3305
5. Grabe N. AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol. 2 (2002) S1-S15
6. Gray N.K., and Hentze M.W. Regulation of protein synthesis by mRNA structure. Mol. Biol. Rep. 19 (1994) 195-200
7. Hackett P.B., Petersen R.B., Hensel C.H., Albericio F., Gunderson S.I., Palmenberg A.C., and Barany G. Synthesis in vitro of a seven amino acid peptide encoded in the leader RNA of Rous sarcoma virus. J. Mol. Biol. 190 (1986) 45-57
8. Harada T., Nishie A., Torigoe K., Ikezaki K., Shono T., Maehara Y., Kuwano M., and Wada M. The specific expression of three novel splice variant forms of human metalloprotease-like disintegrin-like cysteine-rich protein 2 gene in brain tissues and gliomas. Jpn. J. Cancer Res. 91 (2000) 1001-1006
9. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., and Smale S.T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14 (1994) 116-127
10. Kalachikov S., et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat. Genet. 30 (2002) 335-341
11. Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44 (1986) 283-292
12. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196 (1987) 947-950
13. Kozak M. An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115 (1991) 887-903
14. Kozak M. Pushing the limits of the scanning mechanism for initiation of translation. Gene 299 (2002) 1-34
15. Letts V.A., Felix R., Biddlecome G.H., Arikkath J., Mahaffey C.L., Valenzuela A., Bartlett II F.S., Mori Y., Campbell K.P., and Frankel W.N. The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat. Genet. 19 (1998) 340-347
16. Mann B., and Hanski C. Semi-quantitative determination of differential gene expression in primary tumors and matched metastases by RT-PCR. Comparison with other methods. Methods Mol. Biol. 193 (2002) 237-249
17. Mathews D.H., Sabina J., Zuker M., and Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J. Mol. Biol. 288 (1999) 911-940
18. Morante-Redolat J.M., et al. Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum. Mol. Genet. 11 (2002) 1119-1128
19. Osten P., and Stern-Bach Y. Learning from stargazin: the mouse, the phenotype and the unexpected. Curr. Opin. Neurobiol. 16 (2006) 275-280
20. Poindexter K., Nelson N., DuBose R.F., Black R.A., and Cerretti D.P. The identification of seven metalloproteinase-disintegrin (ADAM) genes from genomic libraries. Gene 237 (1999) 61-70
21. Raney A., Baron A.C., Mize G.J., Law G.L., and Morris D.R. In vitro translation of the upstream open reading frame in the mammalian mRNA encoding S-adenosylmethionine decarboxylase. J. Biol. Chem. 275 (2000) 24444-24450
22. Sagane K., Ohya Y., Hasegawa Y., and Tanaka I. Metalloproteinase-like, disintegrin-like, cysteine-rich proteins MDC2 and MDC3: novel human cellular disintegrins highly expressed in the brain. Biochem. J. 334 Pt 1 (1998) 93-98
23. Sagane K., Yamazaki K., Mizui Y., and Tanaka I. Cloning and chromosomal mapping of mouse ADAM11, ADAM22 and ADAM23. Gene 236 (1999) 79-86
24. Sagane K., Hayakawa K., Kai J., Hirohashi T., Takahashi E., Miyamoto N., Ino M., Oki T., Yamazaki K., and Nagasu T. Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci. 6 (2005) 33
25. Steinlein O.K. Genetic mechanisms that underlie epilepsy. Nat. Rev. Neurosci. 5 (2004) 400-408
26. Wang L., and Wessler S.R. Role of mRNA secondary structure in translational repression of the maize transcriptional activator Lc(1,2). Plant Physiol. 125 (2001) 1380-1387
27. Wang X.Q., and Rothnagel J.A. 5′-untranslated regions with multiple upstream AUG codons can support low-level translation via leaky scanning and reinitiation. Nucleic Acids Res. 32 (2004) 1382-1391
28. Weis L., and Reinberg D. Accurate positioning of RNA polymerase II on a natural TATA-less promoter is independent of TATA-binding-protein-associated factors and initiator-binding proteins. Mol. Cell Biol. 17 (1997) 2973-2984
29. White J.M. ADAMs: modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol. 15 (2003) 598-606
30. Wildeboer D., Naus S., Amy Sang Q.X., Bartsch J.W., and Pagenstecher A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J. Neuropathol. Exp. Neurol. 65 (2006) 516-527
31. Wolfsberg T.G., Straight P.D., Gerena R.L., Huovila A.P., Primakoff P., Myles D.G., and White J.M. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. 169 (1995) 378-383